100
Participants
Start Date
October 15, 2018
Primary Completion Date
May 15, 2019
Study Completion Date
December 15, 2019
Investigational device coded KIO014
Innovative chitosan-based biomaterial intended for intraarticular injection.
Durolane(r) as control device
Crosslinked hyaluronic acid-based biomaterial intended for intraarticular injection.
Lead Sponsor
Kiomed Pharma
INDUSTRY